© 2000 American Heart Association, Inc.
Editorials |
Making Sense out of Oxygen Sensor
From the Departments of Medicine and Physiology and Biophysics, State University of New York, Stony Brook, NY.
Correspondence to Michael S. Goligorsky, Health Science Center, Division of Nephrology, State University of New York, Stony Brook, NY 11794-8152. E-mail mgoligorsky{at}mail.som.sunysb.edu
Key Words: oxygen • sensor • mitochondria • nitric oxide • heme proteins
 |
Introduction |
|---|
 Top Introduction References |
|---|
Autoregulatory mechanisms that adjust the diameter of a vascular bed and the blood flow through it to the intrinsic parameters of tissue oxygen demand have become a cornerstone of vascular physiology.1 2 3 4 Although examples of hypoxia-induced vasoconstriction do exist (such as pulmonary microvasculature), most blood vessels respond to hypoxic or ischemic environment with vasodilation. Coronary arteries are not an exception to this rule; in fact, autoregulation in this vascular bed is of paramount importance. Increased myocardial demand for oxygen cannot be met by increasing oxygen extraction, because coronary arteriovenous difference is already high under normal conditions. Therefore, matching the supply depends almost entirely on the ability to increase coronary blood flow.
Although the occurrence of hypoxia- and ischemia-induced coronary vasodilation has been well established, the number of theories attempting to explain the phenomenon has multiplied. Proposed physiological models include (1) direct sensing of reduced PO2 by different cellular elements of the vascular wall5 ; (2) production and release of vasodilatory metabolites by the oxygen-deprived myocardium; (3) changes in intracellular calcium or proton metabolism and distribution, or a rapidly developing deficiency in high-energy phosphates, which suppress the contractile apparatus of the smooth muscle cells5 6 ; and (4) a shift in the affinity of hemoglobin for nitric oxide (NO).7 In this issue of Circulation Research, Shimizu et al8 provide further insight into the mechanisms of hypoxic vasorelaxation in porcine coronary arteries.
Previous studies by Daut et al,9 performed in guinea pigs, demonstrated the existence of glibenclamide-inhibitable coronary vasodilation in response to hypoxia or ischemia. On the basis of these findings, Shimizu et al8 launched a systematic investigation of the effect of K+ channel inhibitors on hypoxic vasorelaxation. The authors used inhibitors of several classes of K+ channels, specifically, Ca2+-dependent (tetraethylammonium, apamin, and charybdotoxin), voltage-dependent (4-aminopyridine), ATP-sensitive (glibenclamide), and inward rectifier (BaCl2), only to conclude that this mechanism is not operant in porcine coronary vessels. In addition, studies using calcium- and pH-sensitive fluorophores showed the lack of a clear correlation between changes in these parameters and hypoxic relaxation. Furthermore, hypoxic vasorelaxation did not appear to be related to the loss of endogenous phosphagens by porcine coronary arteries. Paradoxically, the force of smooth muscle contraction, but not ATP utilization, was increased under hypoxic conditions. To complete the picture, it is important to note that previous studies from the same laboratory using various bona fide pharmacological inhibitors have investigated the validity of several additional candidates for the role of oxygen sensor, including the Na+ pump, eicosanoids, hydrogen peroxide, superoxide, and protein kinases C and G, all of which have failed the selection process for an unambiguous factor responsible for hypoxic vasorelaxation.10 This exhaustive analysis is impressive, and the derived long list of trial-and-error eliminated candidates is palpably helpful, because it provides an ample opportunity to revisit the problem of oxygen sensing and vascular adaptation to oxygen deprivation.
Under the circumstances, it may be time to peer down the evolutionary road to oxygen sensing in bacteria and yeast in an attempt to discern the silhouettes of modern oxygen-sensing systems, such as NAD(P)H oxidase, heme proteins, and P-450 enzymes, as has been done in a recent article by Bunn and Poyton.11 Perhaps the most recent addition to this family of oxygen sensors or effectors, which I find intriguing, has been described in Drosophila.12 Hypoxia produced a series of rapid behavioral changes and induced cell cycle arrest, processes that were diminished by an inhibitor of NO synthase (NOS) and by inactivating mutations in the gene encoding for the cGMP-dependent protein kinase. Moreover, both short- and long-term responses to oxygen deprivation in Drosophila were dependent on NO. Although these examples of hypoxic adaptation are evolutionarily remote, I strongly believe that they may contribute fundamentally to our understanding of the problem of hypoxic relaxation of mammalian arteries. This optimism is based on the following circumstantial evidence.
Tissue responses to hypoxia are orchestrated by NO at different levels: (1) SNO-Hb[Fe(II)]O2 hemoglobin releases NO at decreased PO27 ; (2) glibenclamide-insensitive component of vasodilation could be due to the effect of low PO2 on the vascular endothelium to generate NO, as suggested by Daut et al9 ; (3) NO can be displaced by carbon monoxide from the preexisting, probably heme-bound, cellular pool, where it is constantly replenished by the functioning endothelial NOS, thus exerting a rapid vasodilatory effect independent on the enzymatic machinery, as shown by Thorup et al13 ; and (4) reduction in myocardial O2 consumption, so important in preconditioning, appears to be dependent on NO.14 All of these data point toward the possibility of NO mediation of adaptive responses to hypoxia.
Another breakthrough in our understanding of the oxygen-sensing and
oxygen-signaling system came with the realization that
immunogold-visualized endothelial NOS was detectable
not only on the plasma membrane, as expected, but on the mitochondrial
outer and inner membranes and cristae.15 This enzyme was
further characterized and found to represent a novel isoform,
mitochondrial NOS,16 17 and NO was found to modulate the
respiratory rate and ATP synthesis by inhibiting cytochrome
c oxidase.18 The direct demonstration of
the oxygen- and NO-dependent oxygen consumption in
endothelial cells has been presented most
recently.19 By imposing a continuous gradient of oxygen on
endothelial cells, Clementi et al19 showed
that the decreased oxygen consumption at low
PO2 is mediated by NO inhibition of
the cytochrome oxidase complex, or that "cell respiration was
inhibited in parallel with the generation of NO" (page 1560).
Collectively, these findings provide a more detailed view of the
mitochondrial function, which may have a broad applicability to the
problems of oxygen sensing and hypoxic vasorelaxation. The hypothetical
schema of hypoxic regulation of O2 consumption
and vasorelaxation is summarized in the Figure
. This schema predicts
that the drop in PO2 either
stimulates NO production or liberates NO from heme-binding
sites in the cytoplasm and mitochondrial matrix. Therefore, hypoxic
relaxation is attributed to the cytoplasmic NO release, whereas
hypoxia-induced reduction in oxygen consumption is attributed
to the mitochondrial actions of NO. This schema gives credit to the
existing strong evidence for heme-driven oxygen
signaling.20 21 22 The possible role of yet another potent
vasorelaxing substance, endothelium-derived
hyperpolarizing factor, although shown to play a role in
endothelium-dependent relaxation,23 24
requires definitive experimental proof in hypoxic vessels.
|
In summary, the emerging role of NOS, including the mitochondrial isoform, in orchestrating several vascular responses to hypoxia (eg, relaxation, reduced oxygen consumption, induction of HIF-1, vascular endothelial growth factor, inducible NOS, and glycolytic enzymes) is important. It can explain both the immediate and delayed responses to oxygen deprivation and unleashes an array of intermediary signals, all of which enormously complicate the molecular analysis of this vexed physiological system.
|
Footnotes |
|---|
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
|
References |
|---|
|
TopIntroductionReferences |
|---|
1. Guyton AC, Ross JR, Carrier O, Walker JR. Evidence for tissue oxygen demand as the major factor causing autoregulation. Circ Res. 1964;14–15(suppl 1):60–68.
2. Carrier O, Walker JR, Guyton AC. Role of oxygen in autoregulation of blood flow in isolated vessels. Am J Physiol. 1964;206:951–954.
3.
Smith DJ, Vane JR. Effects of oxygen tension on
vascular and other smooth muscle. J Physiol (Lond). 1966;186:284–294.
4. Furchgott RF. Metabolic factors that influence contractility of vascular smooth muscle. Bull N Y Acad Med. 1966;42:996–1006.[Medline] [Order article via Infotrieve]
5.
Taggart MJ, Wray S. Hypoxia and smooth muscle
function: key regulatory events during metabolic stress.
J Physiol (Lond). 1998;509:315–325.
6.
Chang AE, Detar R. Oxygen and vascular smooth muscle
contraction revisited. Am J Physiol. 1980;238:H716–H728.
7.
Stamler JS, Jia L, Eu JP, McMahon T, Demchenko I,
Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by
S-nitrosohemoglobin in the physiological
oxygen gradient. Science. 1997;276:2034–2037.
8.
Shimizu S, Bowman PS, Thorne G III, Paul RJ. Effects
of hypoxia on isometric force, intracellular
Ca2+, pH, and energetics in porcine
coronary artery. Circ Res. 2000;86:862–870.
9.
Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G,
Gunther K, Goedel-Meinen L. Hypoxic dilation of coronary
arteries is mediated by ATP-sensitive potassium channels.
Science. 1990;247:1341–1344.
10.
Close LA, Bowman PS, Paul RJ.
Reoxygenation-induced relaxation of coronary
arteries: a novel endothelium-dependent mechanism.
Circ Res. 1994;74:870–881.
11.
Bunn HF, Poyton RO. Oxygen sensing and molecular
adaptation to hypoxia. Physiol Rev. 1996;76:839–885.
12. Wingrove JA, O’Farrell PH. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila. Cell. 1999;98:105–114.[Medline] [Order article via Infotrieve]
13.
Thorup C, Jones C, Gross SS, Moore LA, Goligorsky MS.
Carbon monoxide induces vasodilation and nitric oxide release but
suppresses endothelial nitric oxide synthase.
Am J Physiol. 1999;277:F882–F889.
14.
Loke K, McConnell P, Tuzman J, Shesely E, Smith C,
Stackpole C, Thompson C, Kaley G, Wolin MS, Hintze TH.
Endogenous endothelial nitric oxide
synthase-derived nitric oxide is a physiological
regulator of myocardial oxygen consumption. Circ Res. 1999;84:840–845.
15. Bates TE, Loesch A, Burnstock G, Clark JB. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem Biophys Res Commun. 1995;213:896–900.[Medline] [Order article via Infotrieve]
16.
Giulivi C, Poderoso J, Boveris A. Production of
nitric oxide by mitochondria. J Biol Chem. 1998;273:11038–11043.
17.
Tatoyan A, Giulivi C. Purification and characterization
of a nitric oxide synthase from rat liver mitochondria. J
Biol Chem. 1998;273:11044–11048.
18. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J. 1998;332:673–679.
19.
Clementi E, Brown GC, Foxwell N, Moncada S. On the
mechanism by which vascular endothelial cells regulate
their oxygen consumption. Proc Natl Acad Sci U S A. 1999;96:1559–1562.
20.
Gong W, Hao B, Mansy S, Gonzalez G, Gilles-Gonzalez M,
Chan MK. Structure of a biological oxygen sensor: a new mechanism for
heme-driven signal transduction. Proc Natl Acad Sci U S A. 1998;95:15177–15182.
21.
Wang D, Youngson C, Wong V, Yeger H, Dinauer M,
Vega-Saenz de Miera E, Rudy B, Cutz E. NADPH-oxidase and a hydrogen
peroxide-sensitive K+ channel may function as an
oxygen sensor complex in airway chemoreceptors and small cell lung
carcinoma cell lines. Proc Natl Acad Sci U S A. 1996;93:13182–13187.
22. Semenza GL. Perspectives on oxygen sensing. Cell. 1999;98:281–284.[Medline] [Order article via Infotrieve]
23.
Harder DR, Narayanan J, Birks E, Liard J, Imig J,
Lombard J, Lange A, Roman RJ. Identification of a putative
microvascular oxygen sensor. Circ Res. 1996;79:54–61.
24. Fisslhaler B, Popp R, Kiss L, Potente M, Harder D, Flemming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493–497.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  G. D. Thorne, G. M. Hilliard, and R. J. Paul Vascular oxygen sensing: detection of novel candidates by proteomics and organ culture J Appl Physiol, February 1, 2004; 96(2): 802 - 808. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||